Skip to content

Apneic oxygenation with low-flow nasal cannula during induction of general anesthesia in obese children undergoing elective surgery

Apneic oxygenation with low-flow nasal cannula during induction of general anesthesia in obese children undergoing elective surgery

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241206001
Enrollment
82
Registered
2024-12-06
Start date
2024-12-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

desaturation during induction of general anesthesia in obese children apneic oxygenation low-flow nasal cannula induction of general anesthesia obese children

Interventions

apneic oxygenation with low-flow nasal cannula during the apnea phase during induction of general anesthesia with the flow rate according to ages
age 6-12years: cannula flow rate 6 LPM and age 12-18years: cannula flow rate 8 LPM,no apneic oxygenation is provided during apnea phase during induction of general anesthesia
Experimental Device,No Intervention No treatment
apneic oxygenation,no apneic oxygenation

Sponsors

Queen Sirikit National Institute of Child Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. patients with overweight or obesity 2. scheduled to undergo elective surgery under general anesthesia with endotracheal tube or laryngeal mask airway 3. ASA physical status I-II 4. admitted at least 1 day before surgery

Exclusion criteria

Exclusion criteria: 1. morbid obesity 2. severe cardiopulmonary disease with baseline SpO2 less than 95% at room-air 3. severe OSA with AHI score more than 10 4. history of asthmatic attack in the past 1 month 5. severe respiratory tract infection 6. fever with body temperature more than 38 degrees Celsius 7. expected difficult ventilation 8. aspiration risk requiring rapid sequence induction 9. history of allergy to anesthetic drugs

Design outcomes

Primary

MeasureTime frame
safe apnea time SpO2 equals to 95% time spent from ending of mask ventilation until Spo2 equals to 95% (seconds) or reaching the limit of 5 minutes, whichever occured first

Secondary

MeasureTime frame
incidence of desaturation SpO2 less than 95% number of cases that SpO2 less than 95% occurred,lowest SpO2 lowest SpO2 percent of SpO2,CO2 retention in the first 10 breath after resuming mask ventilation highest end-tidal CO2 in the first 10 breath after resuming mask ventilation

Countries

Thailand

Contacts

Public ContactNattawika Phendee

Queen Sirikit National Institute of Child Health

praewpendee@gmail.com1415

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026